Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Uveitis
Interventions
DRUG:
MM-093
OTHER:
Placebo
Sponsor
Merrimack Pharmaceuticals